Oppenheimer Starts Trius Therapeutics (TSRX) at Outperform
Tweet
Share
E-mailGet Alerts TSRX Hot Sheet
Price: $13.63 --0%
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Join SI Premium – FREE
Oppenheimer initiates coverage on Trius Therapeutics (NASDAQ: TSRX) with an Outperform. PT $12.00.
For an analyst ratings summary and ratings history on Trius Therapeutics click here. For more ratings news on Trius Therapeutics click here.
Shares of Trius Therapeutics closed at $7.46 yesterday.
For an analyst ratings summary and ratings history on Trius Therapeutics click here. For more ratings news on Trius Therapeutics click here.
Shares of Trius Therapeutics closed at $7.46 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts Prada SpA (1913:HK) (PRDSY) at Overweight
- Goldman Sachs Starts Hitachi Energy India Ltd (POWERIND:IN) at Buy
- Berenberg Starts Warpaint London plc (W7L:LN) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
